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http://dx.doi.org/10.1016/j.stemcr.2016.04.002SUMMARYHumanmale germ cell tumors (GCTs) are derived from primordial germ cells (PGCs). The master pluripotency regulator and neuroecto-
dermal lineage effector transcription factor SOX2 is repressed in PGCs and the seminoma (SEM) subset of GCTs. Themechanism of SOX2
repression and its significance to GC and GCT development currently are not understood. Here, we show that SOX2 repression in SEM-
derived TCam-2 cells is mediated by the Polycomb repressive complex (PcG) and the repressive H3K27me3 chromatin mark that are
enriched at its promoter. Furthermore, SOX2 repression in TCam-2 cells can be abrogated by recruitment of the constitutively expressed
H3K27 demethylase UTX to the SOX2 promoter through retinoid signaling, leading to expression of neuronal and other lineage genes.
SOX17 has been shown to initiate human PGC specification, with its target PRDM1 suppressing mesendodermal genes. Our results are
consistent with a role for SOX2 repression in normal germline development by suppressing neuroectodermal genes.INTRODUCTION
Human male germ cell tumors (GCTs) are thought to orig-
inate in primordial germ cells (PGCs) most likely by a
mechanism similar to that recently described for the origin
of teratocarcinomas in strain 128 family mice (Heaney
et al., 2012). The key driver for this process is suggested
to be upregulation of genes in the pathways controlling
pluripotency and proliferation, such as NANOG, CCND2,
and RASK2 that map to chromosome 12p (Chaganti and
Houldsworth, 2000; Korkola et al., 2006). GCTs comprise
two main subsets, seminoma (SEM) and nonseminoma
(NS), with a common precursor, germ cell neoplasia
in situ (GCNIS). SEM is unipotent whereas the NS subset
embryonal carcinoma (EC) is pluripotent, analogous to
the blastocyst (Andrews et al., 2005), and has a gene-
expression profile (GEP) similar to that of embryonic
stem cells (ESCs) (Sperger et al., 2003; Josephson et al.,
2007). EC differentiates to extraembryonic (choriocarci-
noma, yolk sac tumor) and embryonic (teratoma) lineages
(Chaganti and Houldsworth, 2000). Comparison of GEPs
of human PGC (hPCG)-like cells derived in vitro from
ESCs, gonadal GCs, and the SEM cell line TCam-2 sug-
gested that SEM arises in PGCs and hence is a good model
system to investigate hPGC biology (Irie et al., 2015).
SOX17 was shown to be the key specifier of hPGC fate,772 Stem Cell Reports j Vol. 6 j 772–783 j May 10, 2016 j ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://creativwith the downstream PRDM1 repressing mesendodermal
genes (Irie et al., 2015).
The core pluripotency regulatory master transcription
factors (TFs) POU5F1 and NANOG are expressed in both
EC and SEM, whereas SOX2 is repressed in hPGCs (Perrett
et al., 2008; Irie et al., 2015), GCNIS, and SEM (Korkola
et al., 2006). Themolecular mechanism of SOX2 repression
in the hPGC-GCNIS-SEM lineage has so far not been
characterized. We show here that SOX2 repression in
TCam-2 cells is due to the co-occupation by the Polycomb
group (PcG) proteins and the repressive chromatin mark
H3K27me3 near its transcription start site (TSS).We further
show that the occupancy of H3K27me3 decreases when
UTX, a H3K27-specific demethylase, is recruited to the
SOX2 promoter in response to retinoid signaling, leading
to SOX2 transcriptional derepression and induction of
neuronal genes, consistent with its function as a neuroec-
todermal effector (Thomson et al., 2011; Zhang and Cui,
2014). Thus, SOX2 repression in TCam-2/SEM is imposed
by PcG and its derepression is regulated by UTX. These
data are consistent with a model of hPGC development
initiated by SOX17, with PRDM1 repressing mesodermal
genes and SOX2 repression inhibiting neuroectodermal
genes.
Although murine and human PGCs re-express pluripo-
tency genes following specification, pluripotency remainsrs
ecommons.org/licenses/by-nc-nd/4.0/).
latent and becomes functional only when PGCs are
cultured in vitro as embryonic germ cells or transform
in vivo as GCTs (Leitch et al., 2013). By analysis of GEPs
of SEM and EC, we show here that the functional path-
ways of SEM reflect their derivation from PGCs, while
those of EC, also derived from PGCs, reflect re-establish-
ment of pluripotency in the transformed PGCs. These
data are of value in understanding the biology of hPGCs
and regulation of the pluripotency state in the unique
GCT system.RESULTS
Functional Programs in SEM and EC Reflect Their
Development from PGCs following Malignant
Transformation and Re-establishment of Pluripotency
Despite their common origin from transformed hPGCs,
SEM retains the germline characteristic of latent pluripo-
tency while EC attains embryonal-like pluripotency. As
such, SEM and EC provide an opportunity to identify the
functional pathways that underlie the latent and patent
pluripotency of the two PGC-derived tumor states. Toward
this end, we performed significance analysis for microarray
(SAM) and gene ontology (GO biological process) analyses
of the upregulated and downregulated genes in the GEPs
of 41 EC and 16 SEM tumors in comparison with those of
five normal testis controls. These GEPs were a subset of
the GEP data of a larger cohort of GCTs representing all
histologic and developmental categories and normal testis
biopsies that we previously published (Korkola et al., 2005,
2006, 2009). SAM analysis showed that upregulated genes
in SEM included the GC genes KIT, CD38, TNAP, SOX17,
NANOS, TFAP2C, and UTF1 consistent with their PGC
derivation as previously shown in the TCam-2 SEM cell
line (Irie et al., 2015) (Tables S1 and S2). GO analysis
identified significantly upregulated categories in SEM
related to DNA integrity (p = 4.5 3 104) and damage
response (4.5 3 105), regulation of cell morphogenesis
(p = 4.86 3 104), and RNA processing (3.7 3 1010),
whereas those in EC related to stem cell maintenance (p =
0.003), cell morphogenesis (p = 4.2 3 107), multicel-
lular organismal process (p = 0.0002), anatomic structure
morphogenesis (p = 8.38 3 107), and response to wound-
ing (p = 8.59 3 1010) (Figure 1). In addition, upregulated
categories representing cell proliferation (pSEM = 1.13 3
103; pEC = 0.0038) and negative regulation of apoptosis
(pSEM = 3.34 3 104; pEC = 4.05 3 105) were common
to both subsets, reflecting their transformed state (Figure 1).
The downregulated categories were remarkably similar in
both subsets and were represented by gamete generation
(pSEM = 6.24 3 1044; pEC = 2.28 3 1045), spermatogen-
esis (pSEM = 7.24 3 1052; pEC = 3.43 3 1057), spermatiddifferentiation (pSEM = 2.68 3 1012; pEC = 2.8 3 1013),
meiotic cycle (pSEM = 3.24 3 1012; pEC = 3.16 3 1012),
and reproduction (pSEM = 7.58 3 1031; pEC = 1.06 3
1030) (Figure 1). These data represent elucidation of regu-
latory pathways in these two subsets.
Computationally Identified SOX2 Targets Involved in
Pluripotency and Differentiation Pathways Are
Significantly Enriched in EC Compared with SEM
We recently assembled a complete in vivo GCT TF interac-
tome (GCTNet) based on the GEPs of tumor biopsies using
the Algorithm for the Reconstruction of Accurate Cellular
Networks (ARACNe) (Kushwaha et al., 2015). GCTNet,
comprising 1,305 TFs and 250,000 interactions, which
encompassed all the functional pathways operating in
this tumor system and inferred all the expressed target
genes of the entire complement of TFs. This analysis
showed that POU5F1, NANOG, and SOX2 had 338, 376,
and 307 ARACNe-inferred individual target genes, respec-
tively. In addition, POU5F1 and NANOG shared 127 com-
mon targets, whereas POU5F1 and SOX2, and NANOG
and SOX2, shared 40 common targets. We validated the
ARACNe-inferred targets of these three genes by analysis
of GEP following their short hairpin RNA-mediated knock-
down (KD) and by genome sequencing following chro-
matin immunoprecipitation (ChIP) in EC-derived NT2/
D1 cells, thus establishing their role as mechanistic tran-
scriptional targets (Kushwaha et al., 2015). We now per-
formed GEP analysis of NT2/D1 and TCam-2 cells and
assessed the enrichment of the previously identified
ARACNe-inferred targets of POU5F1, NANOG, and SOX2
in genes that are differentially expressed between the
two cell lines by gene set enrichment analysis (GSEA)
(Mootha et al., 2003; Subramanian et al., 2005). As shown
in Figure 2A, this analysis clearly shows that whereas target
enrichment was significant for all three TFs between NT2/
D1 and TCam-2 cell lines, SOX2 targets showed enrich-
ment in overexpressed genes in NT2/D1 compared with
TCam-2, while NANOG and POU5F1 showed opposite
enrichment, i.e., in underexpressed genes. Whereas a
GO analysis of GSEA targets of SOX2 overexpressed in
TCam-2 cells identified no significant categories, that of
NT2/D1 cells showed stem cell development (p = 5.11 3
104), cellular developmental process (p = 4.61 3 104),
nervous system development (p = 1.67 3 104), multicel-
lular organismal development (p = 6.99 3 105), system
development (p = 1.94 3 105), anatomical structure
development (p = 1.7 3 105), developmental process (p =
9.93 3 106), and stem cell differentiation (p = 2.09 3
106) among the highly enriched categories. GSEA analysis
of the three TFs from the 41 EC and 16 SEM showed
consistent results (Figure 2B). Indeed, our previous analysis
of POU5F1, NANOG, and SOX2 targets in GCTNet showedStem Cell Reports j Vol. 6 j 772–783 j May 10, 2016 773
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Figure 1. Top GO Categories Enriched in GEPs of SEM and EC in Comparison with Normal Testis
The graphs were prepared using the Cytoscape plugin (BiNGO).
(A and B) Upregulated categories in SEM (A) and EC (B) compared with normal testis.
(C and D) Downregulated categories in SEM (C) and EC (D) compared with normal testis.that whereas NANOG and POU5F1 had largely overlap-
ping programs related to cellular organization and DNA
and cellular metabolism categories, SOX2 controlled a
relatively independent program enriched for categories
representing regulation of histone methylation and modi-
fication, stem cell differentiation, and a variety of differen-
tiation-associated programs including those associated
with neuronal, axonal, and chondrocyte differentiation
(Kushwaha et al., 2015). Taken together, these results estab-
lish that functional pathways related to stem cell and
neuronal development regulated by SOX2 are curtailed in
SEM but restored in EC following re-establishment of
pluripotency.
PRDM1 Does Not Regulate SOX2 in TCam-2 and
NT2/D1 Cells
A recent study showed that ectopic upregulation of PRDM1
in the H9 hES cells and the PA-1, NTERA-2, and NCCIT EC
cells led to downregulation of SOX2 expression, suggesting
direct PRDM1 regulation of SOX2 (Lin et al., 2014). We
investigated the potential role of PRDM1 in regulating
SOX2 expression in TCam-2 and NT2/D1 cells, the latter774 Stem Cell Reports j Vol. 6 j 772–783 j May 10, 2016as SOX2-expressing control, by KD of the gene in these
two cell lines using the relevant SMARTpool small inter-
fering RNAs (siRNAs) and measuring SOX2 mRNA expres-
sion by qRT-PCR at 72 hr following KD. SOX2 expression
wasneitherupregulated inTCam-2 cells nordownregulated
in NT2/D1 cells. We further assayed for PRDM1 and SOX2
expression by immunofluorescence (IF) in NT2/D1 and
PRDM1-KD TCam-2 cells, which confirmed the mRNA
analysis (Figure 3). These results show that PRDM1 does
not directly regulate SOX2 and that some othermechanism
may be involved in keeping the gene repressed in hPGCs
and SEM.
SOX2 Promoter in TCam-2 Cells Is a Target of PcG
We first investigated promoter methylation as a possible
mechanism for SOX2 repression in SEM. We compared
the methylation status of SOX2 promoter in bisulfite-con-
verted DNA from five each of SEM and EC tumors along
with eight EC cell lines (NT2/D1, 27X-1, NCCIT, 169A,
218A, 228A, 2101ep, TERA-1) and the TCam-2 SEM cell
line, quantitating the degree of methylation by mass
spectrometry of amplification products of eight primer
Figure 2. ARACNe-Predicted SOX2 Targets Are Enriched in NT2D/1 Cells and EC Compared with TCam-2 Cells and SEM
(A) GSEA enrichment analysis of targets of (a) SOX2 (p = 0.05), (b) POU5F1 (p = 0.04), and (c) NANOG (p = 0.0) in TCam-2 versus NT2/D1
cells.
(B) GSEA enrichment analysis of targets in EC versus SEM of (a) SOX2 (0.027), (b) POU5F1 (0.5), and (c) NANOG (0.4). All p values are by
two-tailed t test.sets that covered the entire CpG island of the SOX2 pro-
moter (1,000 kbp upstream and 1,000 kbp downstream of
the TSS), using the Sequenom EpiTYPER assay. No methyl-
ation was detected affecting the SOX2 promoter of SEM or
EC tumors, or their derived cell lines (Figures S1A and S1B),
ruling out promoter methylation as the basis for SOX2
repression in SEM.
We then investigated the possibility of epigenetic modi-
fication as the mechanism of SOX2 repression. In
genome-wide mapping studies using human embryonic
fibroblast cells, the SOX2 promoter has previously been
recognized as a target of PcG, being enriched for SUZ12
(Polycomb repressive complex 2 [PRC2]), CBX8 (Poly-
comb repressive complex 1 [PRC1]), and H3K27me3
(Bracken et al., 2006). To investigate whether SOX2 pro-
moter is a target for PcG in human germline cells, weassayed for the co-occupancy of SUZ12, BMI1 (PRC1),
and H3K27me3 at the SOX2 promoter in TCam-2 cells
by ChIP-qPCR. All three components of PcG were en-
riched at the SOX2 promoter, confirming epigenetic
modification as the basis for its transcriptional repression
in TCam-2 cells (Figure 4).
SOX2 Transcription in TCam-2 Cells Is Regulated by
UTX during Retinoid Signaling
UTX, a member of the JumonjiC family TFs, is a di- and
trimethyl H3K27 demethylase that also associates with
mixed-lineage leukemia 2/3 (MLL) complexes possessing
H3K4methyltransferase activity; it occupies the promoters
of HOX gene clusters and modulates their transcrip-
tional output by regulating PRC1 andmonoubiquitination
of H2A in HEK 293 cells (Lee et al., 2007). DuringStem Cell Reports j Vol. 6 j 772–783 j May 10, 2016 775
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Figure 3. SOX2 Expression Is Not Altered
in PRDM1-KD TCam-2 Cells
(A) qRT-PCR analysis of (a) PRDM1 and (b)
SOX2 expression in PRDM1-KD cells following
normalization to PGK1 signal. Data represent
mean ± SD of three independent experi-
ments. ***p > 0.001 by Student’s t test; ns,
not significant.
(B) Representative IF images of (a) NT2D-1,
(b) TCam-2, and (c) PRDM1-KD TCam-2 cells
stained for DAPI (blue), PRDM1 (green), and
SOX2 (red), and merged images. Scale bars
represent 100 mm.retinoid-induced signaling in NT2/D1 cells, recruitment of
UTX to HOX genes results in H3K27 demethylation and
H3K4 methylation, leading to HOXA13 and HOXC4 gene
transcription (Lee et al., 2007). UTX is endogenously
expressed in TCam-2 cells and we reasoned that it may
regulate SOX2 in these cells as well, when challenged to
differentiate. Since retinoid signaling is known to be a ma-
jor regulator of differentiation in stem cells (Gudas and
Wagner, 2011), we induced differentiation in TCam-2 cells
by treatment with all-trans retinoic acid (RA). Western blot
and IF analysis of RA-treated cells showed SOX2 expression
increasing and POU5F1 andNANOGexpression decreasing
from day 2 to day 6 following RA treatment (Figures 5A
and 5C). UTX expression remained constant in treated as
well as untreated cells (Figure 5B). However, ChIP-qPCR
analysis showed significant enrichment of UTX at SOX2
promoter in day-6 RA-treated cells compared with control
cells (Figure 5D).
To investigate the role of UTX in SOX2 repression/dere-
pression, we performed UTX KD in TCam-2 cells using
SMARTpool siRNA and treated the cells with RA for
6 days, and assayed for expression of UTX and SOX2.
SOX2 failed to be upregulated in response to RA in UTX-
depleted cells, indicating UTX requirement for SOX2 dere-776 Stem Cell Reports j Vol. 6 j 772–783 j May 10, 2016pression (Figures 6A and 6B). We then investigated the
mechanism of UTX-regulated SOX2 derepression by assay-
ing the changes in the enrichment of the histone marks
H3K27me3 and H3K4me3 at the SOX2 promoter by ChIP-
qPCR in control (scramble) and UTX-KD cells following
6 days of RA treatment. As expected, the H3K27me3 mark
was enriched in control cells and was reduced upon RA
treatment (Figure 6C). In the UTX-KD cells, however, the
H3K27me3 mark enrichment remained unchanged be-
tween treated and untreated cells, confirming UTX depen-
dence of the repressive mark change in response to RA at
the SOX2 promoter (Figure 6C). RA treatment elicited a
highly significant enrichment of the H3K4me3 mark at
the SOX2 promoter in control cells (Figure 6D). In the
UTX-KD cells the enrichment was significant, but less
than that in the control cells (Figure 6D). Although UTX
is known to associate with MLL complexes that possess
H3K4methyltransferase activity, it is not known to directly
regulate H3K4me3. Thus, these results overall demonstrate
that recruitment of UTX to SOX2 promoter in TCam-2 cells
is associated with a decrease in occupancy of the repressive
H3K27me3 and an increase in occupancy of the activating
H3K4me3 mark, thereby enabling SOX2 derepression in
response to RA signal.
AB
C
Figure 4. PcG Proteins SUZ12 and BMI1 and the Repressive
Chromatin Mark H3K27me3 Are Enriched at SOX2 Promoter in
TCam-2 Cells
ChIP analyses were performed using antibodies for (A) SUZ12, (B)
BMI1, (C) H2K27me3, or immunoglobulin G (IgG) (as nonspecificDerepression of SOX2 Leads to Induction of Neuronal
and Other Lineage Genes in TCam-2 Cells
We obtained the GEP of day-14 RA-treated TCam-2 cells,
which by now were completely differentiated morpholog-
ically, using Affymetrix U133 A plus B arrays, and analyzed
the expression of marker genes related to lineage devel-
opment (Figure S2). The major lineage expressed was
neuronal, with genes such as NEFM, PAX6, NEFL, NESTIN,
TUJI, and TRKC showing significantly higher expression
than in untreated cells. Epithelial and mesodermal genes
such as CDH1, EPCAM, FOXN1, and Twere downregulated
in the RA-treated cells, although KRT was upregulated.
Interestingly, several endodermal genes (DAB2, NODAL,
SPARC) were upregulated while others (SOX17, EPAS1,
GATA4) were downregulated. In addition, smooth muscle
lineage genes such as MEF2C and MYH6 were also ex-
pressed in the differentiated cells. We confirmed the GEP
results on neuronal gene expression by IF analysis using
NEFM, NESTIN, TUJI, and TRKC antibodies (Figure 7A).
We further evaluated by qRT-PCR the status of the neuronal
markers NEUROD4, NEFM, NES, TRKC, and TUJI in control
(scramble) and UTX-KD TCam-2 cells treated with RA to
test the effect of UTX depletion that prevented SOX2 upre-
gulation. The expression of each of these genes was signif-
icantly lower in the UTX-KD cells compared with control
cells in response to RA treatment, confirming the role of
SOX2 in regulating neuronal gene expression (Figure 7B).
We also performed GO analysis of the expressed SOX2
targets predicted by ARACNe in the GEP of the day-14 RA-
treatedTCam-2cells.As shown inFigure7C, theupregulated
target genes represented a variety of developmental pro-
cesses, with nervous system categories predominating: axo-
nogenesis (p = 1.20 3 103), tube development (p = 1.07 3
103), gliogenesis (p=8.033104),nervous systemdevelop-
ment (p = 6.593 104), neuron projection regeneration (p =
6.13 3 104), axon cargo transport (p = 5.26 3 104), axon
regeneration (p = 4.46 3 104), system development (p =
2.24 3 104), stem cell differentiation (p = 1.07 3 104),
anterogradeaxoncargo transport (p=6.843105),multicel-
lular organism development (p = 5.85 3 105), anatomical
structural morphogenesis (p = 4.6 3 105), developmental
process (p = 2.763 106), and anatomical structure develop-
ment (p = 2.343106). These results together confirmdirect
SOX2 regulation of neuroectodermal genes.
Taken together, the data presented above are consistent
with the hypothesis that SOX2 transcription, which is
repressed in TCam-2 as well as in its progenitor hPGC cells,control) in Tcam-2 cells. Plotted values are relative enrichment to
10% input and measured for indicated site in the SOX2 promoter
and GUSB (b-glucuronidase) gene (control). Data represent mean ±
SD of three independent experiments. Student’s t test: ns, not
significant; **p < 0.01; *p < 0.05.
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A Figure 5. SOX2 Is Expressed in TCam-2
Cells following RA Treatment
(A) Immunoblot of RA-treated and untreated
cells showing increased SOX2 (35 kDa)
expression and decreased POU5F1 (39 kDa)
and NANOG (34 kDa) expression over a 6-day
time course. Tubulin (50 kDa) is loading
control.
(B) Immunoblot showing unchanged UTX
(150 kDa) expression over a 6-day time
course. Tubulin (50 kDa) is loading control.
(C) IF showing SOX2, POU5F1, and NANOG
expression following RA treatment. (a)
Untreated TCam-2 cells showing POU5F1
(green), NANOG (magenta), and DAPI (blue),
but not SOX2 (red) expression. (b) RA-treated
TCam-2 cells showing SOX2 but not POU5F1
and NANOG expression. BF is brightfield
image. Scale bars represent 100 mm.
(D) RA-treated and untreated TCam-2 cells
were subjected to ChIP-qPCR using UTX
antibody or an IgG antibody (nonspecific
control). The immunoprecipitated DNA was
subjected to PCR using primers specific to
the SOX2 promoter region. Data represent
mean ± SD of three independent experi-
ments. Student’s t test: ns, not significant;
**p < 0.01; *p < 0.05.is mediated by enrichment of PcG and H3K27me3 at its
bivalent promoter and is regulated by UTX.DISCUSSION
In this studywe show that SOX2 repression in TCam-2 cells
is due to the presence of PcG and H3K27me3 at its pro-
moter and that the repression can be reversed by recruit-
ment of UTX, a H3K27 demethylase to the promoter.
SOX2 repression is a feature of hPGCs, from which SEM
and other GCTs are derived by transformation and upregu-
lation of pluripotency- and proliferation-promoting genes.
PGC specification has been investigated in the greatest
detail in the mouse, where it is regulated by a PGC-spe-
cific transcriptional network composed of the TFs Prdm1,
Prdm14, and Tfap2C, the so-called tripartite network (Mag-
nu´sdo´ttir et al., 2013; Nakaki et al., 2013). Recently, human
GC fate determination has been shown to be different to
that of the murine GC fate (Irie et al., 2015; Surani,
2015). Thus, hPGC specification is suggested to be initiated778 Stem Cell Reports j Vol. 6 j 772–783 j May 10, 2016by SOX17 and its downstream target PRDM1, which re-
presses mesendodermal genes, along with extensive epige-
nome resetting (Tang et al., 2015; Gkountela et al., 2015).
Although the pluripotency factors NANOG, POU5F1,
PRDM14, LIN28A, KLF4, and TFP2CL1 are expressed in
hPGCs as early as 5.5 weeks of gestation (Tang et al.,
2015), pluripotency is kept latent and PGCs remain unipo-
tent or lineage restricted during their entire development.
Human fetal GCs express many of the pluripotency
markers in common with murine PGCs (De Miguel et al.,
2010); however, of the three core pluripotency master reg-
ulators POU5F1, NANOG, and SOX2, only the former two
are expressed whereas SOX2 is repressed (Perrett et al.,
2008; Tang et al., 2015). Nevertheless, post fertilization, hu-
man embryonic blastomeres as well as inner cell mass cells
express SOX2 (Gala´n et al., 2010), implying that its repres-
sion is restricted to germline development. A recent study
showed that in H9 hES cells and EC cell lines, ectopic
expression of PRDM1 led to significant reduction in SOX2
mRNA and protein expression (Lin et al., 2014). The same
study also showed that in a ChIP assay, PRDM1 bound to
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Figure 6. Epigenetic Modifications of SOX2 Promoter Leading to RA-Induced Derepression Are Modulated by UTX
(A) Expression of SOX2, POU5F1, and NANOG in the RA-treated UTX-KD cells compared with scramble (scr) cells in a 6-day time-course
experiment.
(B) qRT-PCR showing expression level of SOX2, NANOG, POU5F1, and UTX in the untreated scr versus UTX-KD cells and treated scr versus
UTX-KD cells. Data represent mean ± SD of the three independent experiments. **p < 0.01 between treated UTX-KD and scr by Student’s
t test.
(C) ChIP-qPCR showing loss of H3K27me3 enrichment at SOX2 promoter of RA-treated scr cells compared with untreated cells, whereas the
enrichment is unchanged in RA-treated UTX-KD cells. Data represent mean ± SD of three independent experiments. Student’s t test: ns, not
significant; **p < 0.01; *p < 0.05.
(D) ChIP-qPCR with H3K4me3 antibody showing enrichment at SOX2 promoter of RA-treated scr cells compared with untreated scr cells and
RA-treated UTX-KD cells compared with untreated KD cells. Data represent mean ± SD of three independent experiments. Student’s t test:
ns, not significant; **p < 0.01; *p < 0.05.
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human SOX2 gene and that PRDM1 suppressed the lucif-
erase activity regulated by this genomic region. Based on
these results, it was suggested that PRDM1 regulates SOX2
during human GC development and acts as a molecular
switch to modulate between neural and germline fates
(Lin et al., 2014). However, neither the mechanism of
SOX2 repression nor its proposed PRDM1 regulation has780 Stem Cell Reports j Vol. 6 j 772–783 j May 10, 2016been demonstrated in hPGCs, GCNIS, or SEM cells, in all
of which SOX2 expression is constitutively repressed. Since
TCam-2 cells are considered to be transformed hPGCs un-
dergoing specification, we investigated the possible control
of SOX2 by PRDM1 in TCam-2 and NT2/D1 cells, in both
of which PRDM1 is expressed. Contrary to expectation,
our results of PRDM1 silencing did not confirm its regula-
tion of SOX2 in either cell type. The discrepancy in results
between the previous study and our studymay be related to
the differing contexts of cellular biology that they repre-
sented. Because the SOX2 promoter is known to be a target
of PcG in human embryonal fibroblast cells (Bracken et al.,
2006), we reasoned that its regulation may also be medi-
ated by an epigenetic modification in TCam-2 cells. Thus,
after ruling out DNA methylation as the mechanism of
repression, we assayed for occupancy of PRC2, PRC1, and
H3K27me3 at the promoter and found enrichment, con-
firming their role in SOX2 repression. We then sought
to alter the enrichment of the repressive epigenetic mark
at the promoter through recruitment of UTX, an H3K27-
specific demethylase, by invoking retinoid signaling in
TCam-2 cells, as was done previously in the case of the
HOX genes in NT2/D1 cells (Lee et al., 2007). RA treatment
resulted in a change in the status of UTX and the chromatin
marks at the SOX2 promoter, leading to derepression of its
transcription and induction of neuronal and other lineage
genes. These results thus show that UTX targets SOX2 for
transcriptional regulation as in the case of HOX genes in
human and Drosophila cells (Lee et al., 2007; Copur and
Mu¨ller, 2013). Our data also are in agreement with the
idea that SOX2 repression is an essential component of
hPGC specification by preventing neuronal gene expres-
sion. Overall, then, hPGC specification appears to bemedi-
ated by three key TFs: SOX17, which initiates the GC
lineage; PRDM1, which represses the mesendodermal line-
age; and SOX2, whose repression prevents neuroectoder-
mal lineage.
SOX2 is an essential factor in the maintenance of both
human and murine pluripotency; however, it is upregu-
lated, along with other pluripotency factors, in murine
PGCs but not hPGCs. In this study we have clarified the
mechanism of its repression in the hPGC-derived TCam-2
SEM cells and suggest that the same mechanism may
be responsible for SOX2 repression in hPGCs. Although
retinoids activated SOX2 expression in TCam-2 cells, this
did not result in restoration of pluripotency as indicated
by the differentiated phenotype and downregulation of
POU5F1 and NANOG in SOX2-expressing TCam-2 cells.
Therefore, our results are relevant specifically to SOX2
biology in human germline, but not necessarily to re-acqui-
sition of pluripotency in EC. The mechanism of the latter
is currently unknown, perhaps requiring epigenetic modi-
fication at several loci, including SOX2. SOX2 regu-
lation overall is complex and invokes multiple pathways
including the action of genes such as POU5F1, NANOG,
STAT3, and SMAD3 (Thomson et al., 2011; Zhang and
Cui, 2014) and, as shown previously and in this study, PcG.
Pluripotency comprises a spectrum of states that present
in vitro and in vivo (Hackett and Surani, 2014). SEMand EC
represent latent and patent versions of hPGCpluripotency;
in addition, in vivo GCT pluripotency is distinct fromembryonal pluripotency in being nontransient and associ-
ated with self-renewal. The functional pathways operating
in SEM and EC in their respective states of pluripotency
have not been characterized so far. In this study, by SAM
of GEPs and GO biological process analyses of the downre-
gulated and upregulated genes in the two subsets in
comparison with normal testes, we show that whereas
SEM retained pathways and processes similar to those in
PGCs, EC was enriched for pathways that regulate stem
cell and development categories; both subsets downregu-
latemeiosis and spermatogenesis categories and upregulate
categories associated with proliferation and self-renewal.
These data provide an insight into their biology and may
represent the starting point for further studies of the
unique sensitivity of GCTs to DNA-damaging agents and
the regulation of pluripotency and self-renewal in this
tumor system.EXPERIMENTAL PROCEDURES
GCT and Cell Line GEPs
Wehave previously reported theGEPs of 141GCTs comprising 135
tumors of all histological types and six normal testes obtained by
using Affymetrix U133 A plus B microarrays (Korkola et al., 2005,
2006, 2009). A subset of these GEPs comprising 16 SEMs and 41
ECs was used in the current analysis using previously described
methods (Kushwaha et al., 2015). GEPs of NT2/D1 and TCam-2
cells were obtained in triplicate using the Affymetrix U133
A plus B microarrays as previously described (Kushwaha et al.,
2015). GEP of TCam-2 cells treated with RA for 14 days were ob-
tained from three biological replicates using Affymetrix A plus B
microarrays.
Cell Lines, Cell Culture, and ATRA Treatment
TCam-2 and NT2/D1 cells were cultured and maintained as
described previously (Eckert et al., 2008; Houldsworth et al.,
2002). For RA treatment, TCam-2 cells were plated at a density
of 2 3 106 per 10-cm plate and treated on the following day
with ATRA (10 mM/ml in medium) (Sigma-Aldrich). Cells were
collected on days 0, 2, 4, and 6 for downstream experiments.
Every 2–3 days, cells were reseeded in the presence of ATRA. The
entire time-course experiment was carried out in triplicate with
untreated cultures as controls.
IF Analysis
TCam-2 cells treatedwithorwithoutATRAwerefixed in4%parafor-
maldehyde. Fixed cells were permeabilized in 0.3% Triton X-100 in
PBS containing 5%normal goat serumand subjected to immunocy-
tochemical analyses aspreviouslydescribed (Kushwahaet al., 2015).
Primary antibodies used for staining were goat anti-SOX2 (1:100)
(catalog #sc17319; Santa Cruz Biotechnology), rabbit anti-NANOG
(1:100) (#ab21624; Abcam), mouse anti-POU5F1 (1:200) (#sc5279;
Santa Cruz), rabbit anti-BLIMP1 (#9115; Cell Signaling Technol-
ogy), mouse anti-Nestin (#sc23927; Santa Cruz), rabbit anti-neuro-
filament (#ab-9034; Abcam), goat anti-TRKC (#ab188592; Abcam),Stem Cell Reports j Vol. 6 j 772–783 j May 10, 2016 781
and mouse anti-TUJ1 (#801201; BioLegend). Appropriate fluores-
cence-labeled secondary antibodies were used for visualization.
Gene Silencing Using a Transient Assay
For silencing of PRDM1 or UTX genes, 0.04 3 106 TCam-2 cells
were plated in 24-well plates 1 day prior to transfection. 80 nM
PRDM1 (ON-TARGETplus Human PRDM1; Dharmacon) siRNA-
SMARTpool or UTX (Dharmacon) siRNA-SMARTpool and control
siRNA (ON-TARGETplus Non-targeting Pool; Dharmacon) were
used to transfect each well using the DharmaFECT1 Transfection
Reagent (Dharmacon). Media were changed after 24 hr of transfec-
tion and cells were collected for studies at different time intervals.
RNA was isolated using Qiazol lysis reagent (Qiagen) and reverse
transcribed using the SuperScript VILO cDNA Synthesis Kit (Life
Technologies). mRNA expression was analyzed by qRT-PCR using
Taqman probes and primer sets in a 7500 Real-Time PCR system
(Applied Biosystems) according to themanufacturer’s instructions.
PGK1mRNA level was used as internal normalization control.
SOX2 Promoter Methylation Assay by EpiTYPER
Analysis
See Supplemental Experimental Procedures and Table S3.
ChIP and ChIP-qPCR
ChIP assay was performed on TCam-2 cells according to methods
previously described by us (Kushwaha et al., 2015). The following
antibodies and reagents were used for immunoprecipitation:
UTX (Abcam #36938), SUZ12 (Millipore #17661), BMI1 (Abcam
#14389), H3K4me3 (pAb) (Active Motif #39159), anti-trimethyl-
histone H3 (Lys 27) (Millipore #07-449), and anti-trimethyl-
histone H3 (Lys4) (Millipore #07-437). A Dynabeads Protein
G immunoprecipitation kit (Life Technologies #10007D) was
used. Immunoprecipitated DNA was purified by phenol-chloro-
form extraction, resuspended in 50ml of Tris-EDTA, and amplified
using oligonucleotides (Table S3). ChIP-qPCRwas performed using
Power SYBR Green PCR Master Mix (Life Technologies #4367659)
on an ABI 7500 cycler.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, two figures, and three tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2016.04.002.
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